Cargando…

A Database of Drug Repurposing Clinical Trials in Oncology

Detalles Bibliográficos
Autores principales:	Pantziarka, Pan, Vandeborne, Liese, Bouche, Gauthier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635986/ https://www.ncbi.nlm.nih.gov/pubmed/34867425 http://dx.doi.org/10.3389/fphar.2021.790952

Ejemplares similares

An Open Access Database of Licensed Cancer Drugs
por: Pantziarka, Pan, et al.
Publicado: (2021)

“Hard” Drug Repurposing for Precision Oncology: The Missing Link?
por: Pantziarka, Pan, et al.
Publicado: (2018)

Repurposing Infectious Diseases Vaccines Against Cancer
por: Vandeborne, Liese, et al.
Publicado: (2021)

ReDO_DB: the repurposing drugs in oncology database
por: Pantziarka, Pan, et al.
Publicado: (2018)

The Repurposing Drugs in Oncology (ReDO) Project
por: Pantziarka, Pan, et al.
Publicado: (2014)

Does the oncology community have a rejection bias when it comes to repurposed drugs?
por: Gyawali, Bishal, et al.
Publicado: (2018)

Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2015)

Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

Repurposing drugs in oncology (ReDO)—cimetidine as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent
por: Sukhatme, Vidula, et al.
Publicado: (2015)

Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent
por: Van Nuffel, An MT, et al.
Publicado: (2015)

Repurposing drugs in oncology (ReDO)—selective PDE5 inhibitors as anti-cancer agents
por: Pantziarka, Pan, et al.
Publicado: (2018)

Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
por: Verbaanderd, Ciska, et al.
Publicado: (2017)

Drug repurposing as a potential source of innovative therapies in cervical cancer
por: Capistrano I., Rica, et al.
Publicado: (2022)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

The wisdom of crowds and the repurposing of artesunate as an anticancer drug
por: Augustin, Yolanda, et al.
Publicado: (2015)

A review of SARS-CoV-2 drug repurposing: databases and machine learning models
por: Elkashlan, Marim, et al.
Publicado: (2023)

Repurposing of drugs for triple negative breast cancer: an overview
por: Spini, Andrea, et al.
Publicado: (2020)

Drug Repurposing by Tumor Tissue Editing
por: Lüke, Florian, et al.
Publicado: (2022)

On the Integration of In Silico Drug Design Methods for Drug Repurposing
por: March-Vila, Eric, et al.
Publicado: (2017)

Editorial: Drug Repurposing for COVID-19 Therapy
por: Maldonado, Rafael, et al.
Publicado: (2021)

Disulfiram in glioma: Literature review of drug repurposing
por: Zhong, Shiyu, et al.
Publicado: (2022)

Screening of GPCR drugs for repurposing in breast cancer
por: Abdulkareem, Noor Mazin, et al.
Publicado: (2022)

Repurposing Clinical Drugs as AdoMetDC Inhibitors Using the SCAR Strategy
por: Zhang, Yan, et al.
Publicado: (2020)

Drug Repurposing for Rare Diseases: A Role for Academia
por: van den Berg, Sibren, et al.
Publicado: (2021)

Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study
por: Gesualdo, Carlo, et al.
Publicado: (2021)

The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

A Computational Model of Tumor Growth and Anakoinosis
por: Pantziarka, Pan, et al.
Publicado: (2019)

Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders
por: Shah, Sweta, et al.
Publicado: (2021)

Challenges for Drug Repurposing in the COVID-19 Pandemic Era
por: Sultana, Janet, et al.
Publicado: (2020)

Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled Clinical Trials
por: Ioakeim-Skoufa, Ignatios, et al.
Publicado: (2023)

Repurposing Cefazolin-Avibactam for the Treatment of Drug Resistant Mycobacterium tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2021)

Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery
por: Li, Xinlei, et al.
Publicado: (2021)

Drug Repurposing of the Anthelmintic Niclosamide to Treat Multidrug-Resistant Leukemia
por: Hamdoun, Sami, et al.
Publicado: (2017)

Editorial: Cancer neuroscience: Drug repurposing targeting the innervated niche
por: Jin, Ming-Zhu, et al.
Publicado: (2023)

Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities
por: Chaffey, Laura, et al.
Publicado: (2022)

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities
por: Porta, Exequiel O. J., et al.
Publicado: (2023)

Enrichment analysis of phenotypic data for drug repurposing in rare diseases
por: Ambesi-Impiombato, Alberto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c8bn57r4f7f0t1l6hdafelou1v